ID
17188
Beschrijving
A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive; ODM derived from: https://clinicaltrials.gov/show/NCT00264537
Link
https://clinicaltrials.gov/show/NCT00264537
Trefwoorden
Versies (1)
- 30-08-16 30-08-16 -
Geüploaded op
30 augustus 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Rheumatoid Arthritis NCT00264537
Eligibility Rheumatoid Arthritis NCT00264537
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
other inflammatory disease
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1290884
- UMLS CUI [1,2]
- C0205394
Beschrijving
disease-modifying anti-rheumatic drugs (dmards)/systemic immunosuppressives
Datatype
boolean
Alias
- UMLS CUI [1]
- C0242708
- UMLS CUI [2]
- C0021081
Beschrijving
treatment with biologic anti-tnf drugs
Datatype
boolean
Alias
- UMLS CUI [1]
- C0281481
Beschrijving
Chronic or recurrent infectious disease
Datatype
boolean
Alias
- UMLS CUI [1]
- C0151317
- UMLS CUI [2]
- C0239998
Beschrijving
Infection
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009450
Similar models
Eligibility Rheumatoid Arthritis NCT00264537
- StudyEvent: Eligibility
C0919936 (UMLS CUI [1,2])
C0451530 (UMLS CUI [2])
C0201657 (UMLS CUI [3])
C0200705 (UMLS CUI [4])
C0457086 (UMLS CUI [5])
C0587240 (UMLS CUI [6])
C2210597 (UMLS CUI [7])
C0201660 (UMLS CUI [8])
C0205360 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
C0021081 (UMLS CUI [2])
C0239998 (UMLS CUI [2])